{"filing":{"accession_number":"0001193125-26-236869","cik":"0000075252","ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"d28678d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312526236869/d28678d8k.htm"},"events":[{"id":10562,"run_id":9264,"accession_number":"0001193125-26-236869","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The disclosure announces the launch of exchange offers and consent solicitations for outstanding senior notes, with the Company offering newly issued 9.000% First Lien Notes and 9.750% Second Lien Notes in exchange. This constitutes a material capital restructuring transaction involving the refinancing and exchange of existing debt obligations, which would materially affect the registrant's financial condition and capital structure. The cautionary language acknowledging that failure to complete the transaction \"could materially adversely affect\" the Company's financial condition further underscores materiality.","company_name":"ACCENDRA HEALTH INC/VA/","ticker":"ACH","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":6902,"accession_number":"0001193125-26-236869","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces the launch of exchange offers and consent solicitations for outstanding senior notes, with the Company offering newly issued 9.000% First Lien Notes and 9.750% Second Lien Notes in exchange. This constitutes a material capital restructuring transaction involving the refinancing and exchange of existing debt obligations, which would materially affect the registrant's financial condition and capital structure. The cautionary language acknowledging that failure to complete the transaction \"could materially adversely affect\" the Company's financial condition further underscores materiality.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:28:12.510067+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6902,"accession_number":"0001193125-26-236869","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces the launch of exchange offers and consent solicitations for outstanding senior notes, with the Company offering newly issued 9.000% First Lien Notes and 9.750% Second Lien Notes in exchange. This constitutes a material capital restructuring transaction involving the refinancing and exchange of existing debt obligations, which would materially affect the registrant's financial condition and capital structure. The cautionary language acknowledging that failure to complete the transaction \"could materially adversely affect\" the Company's financial condition further underscores materiality.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:28:12.510067+00:00","company_name":"ACCENDRA HEALTH INC/VA/","ticker":"ACH","filing_date":"2026-05-22"}]}